You Are Likely To Live Longer Than You Think: Day One Of The 10th ARDD Meeting

Forbes Innovation AI You Are Likely To Live Longer Than You Think: Day One Of The 10th ARDD Meeting Alex Zhavoronkov, PhD Contributor Opinions expressed by Forbes Contributors are their own. Expert in AI for healthcare and longevity biotechnology Following Aug 30, 2023, 08:10pm EDT | Press play to listen to this article! Got it! Share to Facebook Share to Twitter Share to Linkedin John Sedivy, Brown University presenting at the 10th Aging Research and Drug Discovery (ARDD) . .

. [+] meeting in Copenhagen, August 29, 2023 Alex Zhavoronkov, PhD While the Longevity Medicine Day at the 10th Aging Research and Drug Discovery meeting has come to an end, the main program opened on Tuesday, August 29th, 2023. The meeting commenced with an electrifying atmosphere, both in-person and online.

The Grand Hall of the University of Copenhagen was filled to capacity, yet it didn’t feel overcrowded as many attendees also engaged with the event from the yard and conference hotel. The day began with welcoming remarks from the forum chairs, Professor Morten Scheibye-Knudsen , MD, PhD and Daniela Bakula, PhD . Tom Rando of Stanford presenting at the 10th ARDD, Copenhagen, August 29th, 2023 Alex Zhavoronkov, PhD Stanford’s Thomas Rando took the spotlight first with a keynote on “Epigenetic Control of Stem Cell Aging and Rejuvenation,” and provided a deep dive into the molecular mechanisms affecting stem cell function as we age.

Following him, Paul Kohlhaas of Molecule explored innovative financial models for longevity research, emphasizing the role of public markets and decentralized science. Dr. Evelyne Bischof , Chair of the Longevity Medicine Day, presented new insights into the emerging field of age-associated cancers with her lecture on “Geroncology and Healthy Longevity Medicine.

” She provided a comprehensive overview of the current state and future directions of integrating geroscience with clinical practice. The morning session also featured talks by prolific Bente Klarlund Pedersen on the anti-inflammatory effects of exercise, Luigi Ferrucci on protein energetics and splicing in aging, and Andrea Maier on supplements designed to improve healthspan. Dr.

Andrea Maier of the National University of Singapore presenting at the 10th Aging Research and . . .

[+] Drug Discovery Meeting Alex Zhavoronkov, PhD MORE FOR YOU Monkees’ Micky Dolenz, The Final Daydream Believer Today’s ‘Connections’ Answers And Hints For Wednesday, August 30 Ukrainian Jets Will Hunt Russian Drones Using American Heatseekers The afternoon was equally compelling, featuring Anna Katharina Simon ‘s research on autophagy’s role in immune aging and Evandro Fang ‘s multi-disciplinary talk covering aging, Alzheimer’s, autophagy, and artificial intelligence. Sabrina Büttner discussed cellular aging and organelle connectivity, while presentations from Maxwell Biosciences and Deciduous Therapeutics delved into immune-based therapies for aging. Stanford’s Tony Wyss-Coray presented intriguing findings on the plasma proteome as a sensor of organ physiology and aging.

Katrin Andreasson also from Stanford, discussed immune-metabolic mechanisms contributing to cognitive decline. Varun Dwaraka of TruDiagnostic introduced OMICmAge, a multi-omics biological age clock, and Danica Chen from UC Berkeley examined mitochondrial regulation of stem cell aging. The day culminated in a venture capital panel moderated by Lisa Melton of Nature Biotechnology, featuring a diverse set of investors discussing their approaches and challenges in longevity investing.

The presence of editors from Nature Medicine, Nature, and Nature Biotechnology underscored the academic rigor and high impact of the conference. Several emerging longevity companies gave talks on their cutting-edge technologies. Maxwell Biosciences: CEO J.

Scotch McClure presented an “Engineered Immune System” using synthetically designed antibodies. Deciduous Therapeutics: Robin Mansukhani discussed targeting cellular senescence through immune mobilization. TruDiagnostic: Varun Dwaraka introduced OMICmAge, a multi-omics age predictor.

Ichor Life Sciences: Kelsey Moody talked about developing next-gen lysosomal biologics. Life Biosciences: Sharon Rosenzweig-Lipson presented on epigenetic reprogramming for age-related disease. Poster Session at the 10th ARDD, August 29, 2023 Alex Zhavoronkov, PhD The poster sessions transpired in the epic hallway of the Grand Hall.

The ARDD is famous for its poster sessions as many of these posters get noticed by the journal editors on site increasing the chances of the full paper to be published in one of the top journals. Multiple startups set up their booths at the tent in the backyard of the Grand Hall of the University of Copenhagen showcasing their solutions, products, kits and giving away cool merchandise. Speakers and delegates alike were using the tent for private discussions.

I was very glad to see Tom Rando of Stanford and Vadim Gladyshev of Harvard having meetings with their likely collaborators at the same time. Executive chair of the 10th ARDD, Morten Scheibye-Knudsen showing the new startup tent, August 29, . .

. [+] 2023 Alex Zhavoronkov, PhD Alex Zhavoronkov of Insilico, Anastasia Georgievskaya, CEO of Haut. AI, and Gérôme Guiot of the LVMH .

. . [+] at the 10th Aging Research and Drug Discovery Meeting.

Alex Zhavoronkov, PhD I was very happy to Gérôme Guiot , BCG veteran and director of strategic initiatives at LVMH. Here, I may speculate that LVMH is also developing interest in aging research and longevity biotechnology. The Youth Longevity Association Members and young female scientists in longevity at the 10th ARDD, .

. . [+] August 29, 2023 Alex Zhavoronkov, PhD And the presence of the Youth Longevity Association (TYLA) members – high school students who are already developing their career pathways in longevity biotechnology, served as a reminder that longevity biotechnology is a long game and to succeed we need to develop the next generation of scientific leaders and entrepreneurs.

With over 5,000 online viewers and a hallway constantly buzzing with discussions, the first day of ARDD 2023 was a testament to the maturing longevity biotechnology industry. The event set a high bar for the days to follow, offering a rich blend of content that spanned from basic science to clinical translation, all aimed at extending the healthy human lifespan. It clearly feels like the future is better than we think and many advances in biotechnology and aging research are likely to yield very effective longevity interventions within our lifetimes.

Follow me on Twitter or LinkedIn . Check out my website or some of my other work here . Alex Zhavoronkov, PhD Editorial Standards Print Reprints & Permissions.